stella
beta
A Long-term Study Evaluating Hepatotoxicity Associated With TURALIO™ (Pexidartinib) Treatment — Stella
Home
/
Hepatotoxicity
/
A Long-term Study Evaluating Hepatotoxicity Associated With TURALIO™ (Pexidartinib) Treatment
View on ClinicalTrials.gov
Recruiting
Back to Hepatotoxicity trials
A Long-term Study Evaluating Hepatotoxicity Associated With TURALIO™ (Pexidartinib) Treatment
Trial locations
(8 sites)
United States
Kamalesh K Sankhala MD INC, Santa Monica, California
Sarcoma Oncology Research Center LLC, Santa Monica, California
UCLA Hematology and Oncology, Santa Monica, California
The Oncology Institute of Hope and Innovation, Whittier, California
Dana-Farber Cancer Institute, Boston, Massachusetts
Montefiore Medical Center, New York, New York
OSU - James Comprehensive Cancer Center, Columbus, Ohio
Kelsey Seybold Clinic - Pearland, Houston, Texas